Financial Ratios

ROSSARI BIOTECH LTD.

NSE : ROSSARIBSE : 543213ISIN CODE : INE02A801020Industry : ChemicalsHouse : Private
BSE720.90-13.75 (-1.87 %)
PREV CLOSE ( ) 734.65
OPEN PRICE ( ) 703.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5119
TODAY'S LOW / HIGH ( )703.10 741.15
52 WK LOW / HIGH ( )665.25 903.45
NSE726.85-7.85 (-1.07 %)
PREV CLOSE( ) 734.70
OPEN PRICE ( ) 725.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 726.85 (1084)
VOLUME 59277
TODAY'S LOW / HIGH( ) 714.70 742.65
52 WK LOW / HIGH ( )656.95 903.85
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)12.9414.4415.2312.91104.07
   CEPS(Rs)17.6519.2119.4816.2311.98
   DPS(Rs)0.500.500.500.505.00
   Book NAV/Share(Rs)155.05141.9077.4855.76273.50
   Tax Rate(%)25.3625.5025.3725.6327.83
Margin Ratios
   Core EBITDA Margin(%)12.1511.0617.2317.4115.04
   EBIT Margin(%)10.1410.0915.5315.2212.92
   Pre Tax Margin(%)9.689.8615.1114.6112.29
   PAT Margin (%)7.227.3411.2710.868.87
   Cash Profit Margin (%)9.859.7714.4213.6611.23
Performance Ratios
   ROA(%)6.249.5713.7716.3220.79
   ROE(%)8.7313.4323.0832.4943.64
   ROCE(%)11.7418.3728.8838.4756.07
   Asset Turnover(x)0.861.301.221.502.34
   Sales/Fixed Asset(x)3.914.594.095.786.06
   Working Capital/Sales(x)4.114.753.503.4714.98
Efficiency Ratios
   Fixed Capital/Sales(x)0.260.220.240.170.16
   Receivable days78.4453.6760.1254.2851.38
   Inventory Days40.6733.0438.1634.2131.81
   Payable days76.3853.1289.1599.6577.48
Valuation Parameters
   PER(x)46.0063.2968.120.000.00
   PCE(x)33.7247.5653.260.000.00
   Price/Book(x)3.846.4413.390.000.00
   Yield(%)0.080.050.05
   EV/Net Sales(x)3.354.667.68-0.080.01
   EV/Core EBITDA(x)25.8836.8640.46-0.460.06
   EV/EBIT(x)32.5945.7348.65-0.550.07
   EV/CE(x)2.604.848.45-0.100.02
   M Cap / Sales3.374.697.800.000.00
Growth Ratio
   Net Sales Growth(%)-9.1055.3915.0516.3276.81
   Core EBITDA Growth(%)-6.823.3820.6437.6873.34
   EBIT Growth(%)-8.210.2218.7437.5765.05
   PAT Growth(%)-10.170.4720.7343.0958.31
   EPS Growth(%)-10.34-5.2317.99-87.6058.31
Financial Stability Ratios
   Total Debt/Equity(x)0.080.000.000.240.05
   Current Ratio(x)1.792.192.212.031.28
   Quick Ratio(x)1.421.631.681.690.84
   Interest Cover(x)21.7142.9236.4324.9620.42
   Total Debt/Mcap(x)0.020.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.